Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 4, 2015, Pages 2136-2143

  Azad, Mohammad A K ^a   Akter, Jesmin ^a   Rogers, Kelly L ^b   Nation, Roger L ^a   Velkov, Tony ^a   Li, Jian ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; FAS LIGAND; POLYMYXIN B; STAUROSPORINE; SUPEROXIDE; ANTIINFECTIVE AGENT; CASPASE; POLYMYXIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR PATHOLOGY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; KIDNEY DISEASE; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; CASPASES; CELLS, CULTURED; ENZYME ACTIVATION; FAS LIGAND PROTEIN; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; POLYMYXINS; RATS; SUPEROXIDES;

EID: 84928910524     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04869-14     Document Type: Article

References (47)

1. Blot S, Vandewoude K, De Bacquer D, Colardyn F. 2002. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 34:1600-1606. http://dx.doi.org/10.1086/340616.
2. Velkov T, Thompson PE, Nation RL, Li J. 2010. Structure-activity relationships of polymyxin antibiotics. J Med Chem 53:1898-1916. http://dx.doi.org/10.1021/jm900999h.
3. Boucher HW, Talbot GH, Benjamin DK, Jr, Bradley J, Guidos RJ, Jones RN, Murray BE, Bonomo RA, Gilbert D. 2013. 10 x '20 progress-development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 56:1685-1694. http://dx.doi.org/10.1093/cid/cit152.
4. Butler MS, Blaskovich MA, Cooper MA. 2013. Antibiotics in the clinical pipeline in 2013. J Antibiot (Tokyo) 66:571-591. http://dx.doi.org/10.1038/ja.2013.86.
5. Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL. 2011. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 55:3284-3294. http://dx.doi.org/10.1128/AAC.01733-10.
6. Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, Behle TF, Bordinhao RC, Wang J, Forrest A, Nation RL, Li J, Zavascki AP. 2013. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis 57:524-531. http://dx.doi.org/10.1093/cid/cit334.
7. Zavascki AP, Goldani LZ, Li J, Nation RL. 2007. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60:1206-1215. http://dx.doi.org/10.1093/jac/dkm357.
8. Kubin CJ, Ellman TM, Phadke V, Haynes LJ, Calfee DP, Yin MT. 2012. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. J Infect 65:80-87. http://dx.doi.org/10.1016/j.jinf.2012.01.015.
9. Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. 2003. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob Agents Chemother 47:1766-1770. http://dx.doi.org/10.1128/AAC.47.5.1766-1770.2003.
10. Ma Z, Wang J, Nation RL, Li J, Turnidge JD, Coulthard K, Milne RW. 2009. Renal disposition of colistin in the isolated perfused rat kidney. Antimicrob Agents Chemother 53:2857-2864. http://dx.doi.org/10.1128/AAC.00030-09.
11. Abdelraouf K, Braggs KH, Yin T, Truong LD, Hu M, Tam VH. 2012. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother 56:4625-4629. http://dx.doi.org/10.1128/AAC.00280-12.
12. Pedersen MF, Pedersen JF, Adsen PO. 1971. A clinical and experimental comparative study of sodium colistimethate and polymyxin B sulfate. Invest Urol 9:234-237.
13. Eadon MT, Hack BK, Alexander JJ, Xu C, Dolan ME, Cunningham PN. 2013. Cell cycle arrest in a model of colistin nephrotoxicity. Physiol Genomics 45:877-888. http://dx.doi.org/10.1152/physiolgenomics.00076.2013.
14. Hartzell JD, Neff R, Ake J, Howard R, Olson S, Paolino K, Vishnepolsky M, Weintrob A, Wortmann G. 2009. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 48:1724-1728. http://dx.doi.org/10.1086/599225.
15. Azad MA, Roberts KD, Yu HH, Liu B, Schofield AV, James SA, Howard DL, Nation RL, Rogers K, de Jonge MD, Thompson PE, Fu J, Velkov T, Li J. 2015. Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach. Anal Chem 87:1590-1595. http://dx.doi.org/10.1021/ac504516k.
16. Suzuki T, Yamaguchi H, Ogura J, Kobayashi M, Yamada T, Iseki K. 2013. Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother 57:6319-6324. http://dx.doi.org/10.1128/AAC.00254-13.
17. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. 1995. Cytotoxicity-dependent Apo-1 (Fas/Cd95)-associated proteins form a death-inducing signaling complex (Disc) with the receptor. EMBO J 14:5579-5588.
18. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. 1991. The polypeptide encoded by the cDNA for human cell-surface antigen Fas can mediate apoptosis. Cell 66:233-http://dx.doi.org/10.1016/0092-8674(91)90614-5.
19. Gottlieb E, Armour SM, Harris MH, Thompson CB. 2003. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10:709-717. http://dx.doi.org/10.1038/sj.cdd.4401231.
20. Ferrarini M, Delfanti F, Gianolini M, Rizzi C, Alfano M, Lazzarin A, Biswas P. 2008. NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short-versus long-term cultured human gamma delta lymphocytes. J Immunol 181:5857-5864. http://dx.doi.org/10.4049/jimmunol.181.9.5857.
21. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
22. Pellegrin S, Heesom KJ, Satchwell TJ, Hawley BR, Daniels G, van den Akker E, Toye AM. 2012. Differential proteomic analysis of human erythroblasts undergoing apoptosis induced by epo-withdrawal. PLoS One 7:e38356. http://dx.doi.org/10.1371/journal.pone.0038356.
23. Jhun BS, Lee H, Jin ZG, Yoon Y. 2013. Glucose stimulation induces dynamic change of mitochondrial morphology to promote insulin secretion in the insulinoma cell line INS-1E. PLoS One 8:e60810. http://dx.doi.org/10.1371/journal.pone.0060810.
24. Mitra K, Lippincott-Schwartz J. 2010. Analysis of mitochondrial dynamics and functions using imaging approaches. Curr Protoc Cell Biol 46:4.25: 4.25.1-4.25.21. http://dx.doi.org/10.1002/0471143030.cb0425s46.
25. Shah A, Xia L, Goldberg H, Lee KW, Quaggin SE, Fantus IG. 2013. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J Biol Chem 288:6835-6848. http://dx.doi.org/10.1074/jbc.M112.419101.
26. Hartig SM. 2013. Basic image analysis and manipulation in ImageJ. Curr Protoc Mol Biol 102:14.15:14.15.1-14.15.12. http://dx.doi.org/10.1002/0471142727.mb1415s102.
27. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, Korsmeyer SJ. 2002. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2:55-67. http://dx.doi.org/10.1016/S1534-5807(01)00116-2.
28. Karbowski M, Youle RJ. 2003. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ 10:870-880. http://dx.doi.org/10.1038/sj.cdd.4401260.
29. Azad MA, Finnin BA, Poudyal A, Davis K, Li J, Hill PA, Nation RL, Velkov T, Li J. 2013. Polymyxin B induces apoptosis in kidney proximal tubular cells. Antimicrob Agents Chemother 57:4329-4335. http://dx.doi.org/10.1128/AAC.02587-12.
30. Yousef JM, Chen G, Hill PA, Nation RL, Li J. 2012. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother 67:452-459. http://dx.doi.org/10.1093/jac/dkr483.
31. Dai C, Li J, Tang S, Li J, Xiao X. 2014. Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother 58:4075-4085. http://dx.doi.org/10.1128/AAC.00070-14.
32. Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257. http://dx.doi.org/10.1038/bjc.1972.33.
33. Igney FH, Krammer PH. 2002. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2:277-288. http://dx.doi.org/10.1038/nrc 776.
34. Guicciardi ME, Gores GJ. 2009. Life and death by death receptors. FASEB J 23:1625-1637. http://dx.doi.org/10.1096/fj.08-111005.
35. Krammer PH, Arnold R, Lavrik IN. 2007. Life and death in peripheral T cells. Nat Rev Immunol 7:532-542. http://dx.doi.org/10.1038/nri2115.
36. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. 2004. Toxic proteins released from mitochondria in cell death. Oncogene 23:2861-2874. http://dx.doi.org/10.1038/sj.onc.1207523.
37. Sakahira H, Enari M, Nagata S. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99. http://dx.doi.org/10.1038/34214.
38. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ. 2004. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23:2134-2145. http://dx.doi.org/10.1038/sj.emboj.7600210.
39. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490. http://dx.doi.org/10.1016/S0092-8674(00)81589-5.
40. Wang CX, Youle RJ. 2009. The role of mitochondria in apoptosis. Annu Rev Genet 43:95-118. http://dx.doi.org/10.1146/annurev-genet-102108-134850.
41. Suda T, Takahashi T, Golstein P, Nagata S. 1993. Molecular-cloning and expression of the Fas ligand, a novel member of the tumornecrosis-factor family. Cell 75:1169-1178. http://dx.doi.org/10.1016/0092-8674(93)90326-L.
42. Linkermann A, Himmerkus N, Rolver L, Keyser KA, Steen P, Brasen JH, Bleich M, Kunzendorf U, Krautwald S. 2011. Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int 79:169-178. http://dx.doi.org/10.1038/ki.2010.317.
43. Zou H, Li YC, Liu HS, Wang XD. 1999. An APAF-1 center dot cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549-11556. http://dx.doi.org/10.1074/jbc.274.17.11549.
44. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ. 2001. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1:515-525. http://dx.doi.org/10.1016/S1534-5807(01)00055-7.
45. Santin G, Piccolini VM, Barni S, Veneroni P, Giansanti V, Dal Bo V, Bernocchi G, Bottone MG. 2013. Mitochondrial fusion: a mechanism of cisplatin-induced resistance in neuroblastoma cells? Neurotoxicology 34: 51-60. http://dx.doi.org/10.1016/j.neuro.2012.10.011.
46. Wu SN, Zhou FF, Zhang ZZ, Xing D. 2011. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J 278:941-954. http://dx.doi.org/10.1111/j.1742-4658.2011.08010.x.
47. Yousef JM, Chen G, Hill PA, Nation RL, Li J. 2011. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother 55:4044-4049. http://dx.doi.org/10.1128/AAC.00328-11.